Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous rt-PA for stroke.

David C Tong1

  • 1Stanford Stroke Center, California, USA. dct@stanford.edu

Current Medical Research and Opinion
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Thrombolytic therapy is a powerful treatment for acute ischemic stroke, improving outcomes with minimal bleeding risk. Early treatment within 3 hours is recommended for most patients with significant deficits and no hemorrhage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.

Circulation·2021
Same author

Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population.

American journal of nephrology·2021
Same author

Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.

European heart journal·2021
Same author

Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study.

BMJ open·2021
Same author

Use of a Telemedicine Risk Assessment Tool to Predict the Risk of Hospitalization of 496 Outpatients With COVID-19: Retrospective Analysis.

JMIR public health and surveillance·2021
Same author

Utility of Zwolle Risk Score in Guiding Low-Risk STEMI Discharge.

Heart, lung & circulation·2020
Same journal

Treatment patterns among pediatric and adult patients with ulcerative colitis in the United States: a retrospective cohort study.

Current medical research and opinion·2026
Same journal

Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

Current medical research and opinion·2026
Same journal

RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

Current medical research and opinion·2026
Same journal

Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

Current medical research and opinion·2026
Same journal

Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

Current medical research and opinion·2026
Same journal

BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

Current medical research and opinion·2026
See all related articles

Area of Science:

  • Neurology
  • Emergency Medicine
  • Radiology

Background:

  • Thrombolytic therapy is the primary treatment for acute ischemic stroke.
  • Concerns regarding subtle early CT infarct signs have been largely dismissed.
  • Treatment offers significant neurological improvement with a manageable increase in hemorrhage risk.

Purpose of the Study:

  • To evaluate the efficacy and safety of thrombolytic therapy for acute ischemic stroke.
  • To determine the optimal time window for thrombolytic treatment.
  • To assess the impact of early CT findings on treatment decisions.

Main Methods:

  • Review of clinical data and outcomes for patients receiving thrombolytic therapy.
  • Analysis of neuroimaging (CT) to identify early ischemic changes.

Related Experiment Videos

  • Subgroup analysis based on stroke severity and time to treatment.

    • Main Results:

    • Thrombolytic therapy significantly improves neurological outcomes.
    • Early CT signs of infarct do not preclude treatment benefits.
    • Patients treated within 3 hours show the most significant benefits.
    • Even severe stroke patients may benefit, though to a lesser extent.
    • Community studies confirm efficacy in routine practice.

    Conclusions:

    • Thrombolytic therapy is highly effective for acute ischemic stroke within the 3-hour window.
    • Early head imaging is crucial for identifying eligible patients.
    • Treatment benefits extend to selected severe stroke cases.
    • Further research is needed for treatment beyond 3 hours.